Print Page     Close Window     

Download Mesoblast Corporate Backgrounder

Mesoblast Corporate Backgrounder (350 KB)

Mesoblast is a world leader in developing innovative cellular medicines.

The Company has established what it believes is the industry's most clinically advanced and diverse portfolio of cell-based product candidates ... More

Latest ASX AnnouncementsMore
16 October 2018
Change in substantial holding
... 
12 October 2018
Completion of Tasly Transaction, and Appendix 3B
... 
11 October 2018
Release of shares from voluntary escrow
... 
02 October 2018
End-Stage HF Results Selected For AHA Scientific Sessions
... 
Upcoming EventsMore
There are currently no events scheduled.
Stock QuoteMore
Exchange :ASX
Price :A$2.03
Change : Stock is Down 0.03 (1.46%)
Volume :434,839
Data as of 16 October 2018 3:11 p.m. ET
Data provided by Nasdaq Minimum 15 minutes delay
Download Documentation Financial Results for the 2018 Full Financial Year, 4th Quarter Ended June 30, 2018
Download Documentation Financial Results for the Period Ended September 30, 2017
Download Documentation 2017 Annual Report
Download Documentation Financial Results for the Three Months and for the Year Ended June 30, 2017
E-mail Alerts
Sign up to receive e-mail alerts.

Copyright © 2015 Mesoblast Inc.